Pfeiffenberger Brent 4
4 · Century Therapeutics, Inc. · Filed May 20, 2025
Insider Transaction Report
Form 4
Pfeiffenberger Brent
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-05-16$0.55/sh−29,552$16,135→ 1,682,258 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.